DJIA 16,987.51 -61.49 -0.36%
NASDAQ 4,567.60 -24.21 -0.53%
S&P 500 1,985.54 -11.91 -0.60%
market minute promo

122.05 1.64 (1.36%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $122.05 1.36%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $120.23
Previous Close $120.41
Daily Range $120.07 - $122.16
52-Week Range $98.61 - $153.10
Market Cap $40.9B
P/E Ratio -51.24
Dividend (Yield) $0.00 (0.0%)
Volume 2,500,847
Average Daily Volume 2,832,058
Current FY EPS $2.96

Sector

Healthcare

Industry

Drugs

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

3 Questions for Allergan Inc.

Allergan is fighting tooth and nail to remain independent from Valeant Pharmaceuticals. Here are three questions investors should know the answers to heading into what is looking like the endgame.

Will Allergan's Board Be Revamped to Aid Valeant Buyout? - Analyst Blog

William Ackman Sends Letter To Allergen Board

Valeant: One Big Injection

Allergan OKs Special Shareholder Meeting Consents

Unilens Vision: 50% Near-Term Upside With Long-Term Multibagger Potential

Most Held Canadian Stocks of the Second Quarter

The Top Net Buys Of The Hedge Fund Gurus

Open Your Eyes To Cooper Companies

Misleading Statements In The Ruane, Cunniff, Goldfarb Annual Meeting Transcript Regarding Valeant An

Misleading Statements In The Ruane, Cunniff, Goldfarb Annual Meeting Transcript Regarding Valeant And Allergan

Today's Top Performers In Drugs

See More VRX News...

VRX's Top Competitors

VRX $122.05 (1.36%)
Current stock: VRX
JNJ $104.58 (0.03%)
Current stock: JNJ
NVS $93.76 (-0.64%)
Current stock: NVS
RHHBY $36.70 (-0.54%)
Current stock: RHHBY